Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucokinase (GK), also known as hexokinase IV or hexokinase D, is a key enzyme in glucose metabolism and homeostasis. It catalyzes the phosphorylation of glucose to glucose-6-phosphate (G6P), the first step in both glycogen synthesis and glycolysis in the liver and pancreas. It acts as a glucose sensor, especially in pancreatic β-cells for insulin release regulation, but also plays roles in other cells involved in overall glucose homeostasis.
Glucokinase activators increase the activity of glucokinase, leading to increased glucose metabolism and insulin secretion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucokinase (GK).